Pulmonology & Thoracic Surgery
Recently Added |View All
Temple Lung Center | Enrolling Clinical Trials
The Temple Lung Center conducts one of the most comprehensive lung disease clinical trials programs in the country. Our advancements in basic, translational and clinical research are changing lung disease treatment. By pioneering effective ...
Temple Lung Center Performs First Procedure in AIRFLOW-4 Clinical Trial for COPD
The Temple Lung Center has performed the first procedure in the AIRFLOW-4 clinical trial, evaluating the investigational dNerva® Lung Denervation System — a novel, non-implant, bronchoscopic therapy designed to target the underlying neural ...
FAQ: Building and Scaling a High-Performance Lung Transplant Program
Lung transplantation remains one of the most complex, resource-intensive interventions in pulmonary medicine, requiring precise coordination across disciplines, rapid evaluation pathways, and long-term patient management strategies.
Temple Lung Center at ATS 2026: Conference Recap
The American Thoracic Society's 2026 International Conference brought together leading voices in pulmonary, critical care, and sleep medicine — and Temple Health was well represented.
Temple Lung Center Joins National Bronchiectasis and NTM Care Center Network
Temple Lung Center is proud to announce its official designation as a member of the Bronchiectasis and NTM Care Center Network, a national collaborative dedicated to advancing research, improving standards of care, and expanding access ...
Temple Lung Center: Advances in Lung Care and Research in 2025
Pulmonary care is evolving rapidly, from earlier detection strategies to new minimally invasive therapies and expanding access to clinical trials.
COPD Clinical Trials at Temple Lung Center
Chronic obstructive pulmonary disease (COPD) remains a major cause of morbidity, and many patients continue to experience symptoms despite optimal therapy. As one of the world’s largest and most experienced COPD research programs, the ...
Temple Sets New National Record in Lung Transplant
The Temple Lung Center is one of the most active and experienced lung transplant programs in the world - and a national destination for complex, high-risk patients.
2026 GOLD Report: A Landmark Revision Shaping the Future of COPD Management
The Temple Lung Center continues to play a defining role in advancing the global standard of care for patients with chronic obstructive pulmonary disease (COPD). As a contributor to the international dialogue on evidence-based best practices, ...
Temple Lung Center Performs First U.S. BREATHE-3 Procedure for Severe Emphysema
The Phase-3 trial of Apreo Health’s bronchoscopic airway scaffold for severe emphysema and hyperinflation is now enrolling at the Temple Lung Center.
Course
AI-Powered LDCT: Temple Establishes New Paradigm for Lung Disease Detection
Pulmonologists are at the forefront of detecting and managing lung disease - and now, artificial intelligence (AI) is redefining what’s possible in early detection and workflow efficiency. The Temple Lung Center has become the first pulmonary ...
Temple Lung Center: Advancing Research in ILD
Interstitial lung diseases (ILD) significantly impact patient morbidity and mortality. As an ILD Center of Excellence, the Temple Lung Center has established comprehensive programs for the evaluation and management of patients with a wide ...
March Quarterly Impact Report: Temple Healthy Chest Initiative
screenings since program inception. Research shows that roughly 70% of patients undergoing lung cancer screening will have some radiographic abnormality in their scan results. This report outlines steps the Temple Healthy Chest Initiative ...
Temple Lung Center: Advances in Lung Care and Research in 2024
The Temple Lung Center continued to set the standard in lung health throughout 2024, delivering exceptional clinical care and advancing lung disease research. Through expanded screening programs and innovative clinical trials, our multidisciplinary ...
LDCT+: A New Approach in Early Lung Disease Detection - Webinar
View Archive of this live webinar | Annual low-dose computed tomography (LDCT) screening has transformed early lung cancer detection, yet many patients remain underdiagnosed for coexisting conditions like COPD—an independent risk factor ...
Course
Interstitial Lung Disease (ILD) and Associated Pulmonary Hypertension
Interstitial lung disease (ILD) is a commonly encountered disease state. Patients who develop ILD associated with pulmonary hypertension have an increased mortality risk. This program aims to review the classification of commonly encountered ...
Temple Lung Center: Advancing Research in COPD
The Temple Lung Center is one of the world’s largest COPD research centers, and has demonstrated its commitment to offer innovative therapies to patients by applying research breakthroughs to clinical care.
Lung Transplantation for COPD Patients
Chronic Obstructive Pulmonary Disease (COPD) is the sixth leading cause of death in the U.S., affecting nearly 16 million adults. Dr. Gerard Criner, Director of the Temple Lung Center, recently joined the Global Forum on Lung Transplantation ...
November Quarterly Impact Report: The Temple Healthy Chest Initiative
The American Cancer Society is forecasting more than two million new cases of cancer to be diagnosed in the year 2024. And while the incidence rate is on the rise, cancer-related deaths continue to decline. Early detection is key to producing ...
A comprehensive overview of strategic clinical risk stratification, evidence-based approaches derived from clinical trials and advanced research, and essential insights into the follow-up care of patients post-pulmonary embolism (PE).

